Lopinavir Completed Phase 1 Trials for Plasmodium Infections / Human Immunodeficiency Virus (HIV) Infections Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT00307502Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
NCT00665951Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
NCT00697892Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations
NCT00135434Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism
NCT00038480Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants
NCT00004580A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
NCT00767117TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.